Deal ensures continued access to inclisiran (Leqvio)

Reminder that NHS England's renewed deal with Novartis keeps inclisiran available within the lipid management pathway.

NHS England · Primary Care Bulletin item

Deal ensures continued access to inclisiran (Leqvio)

Published 23 October 2025 · Prescribing & medicines

← NHS England Primary Care Bulletin – 23 October 2025

NHSENews

In brief Reminder that NHS England's renewed deal with Novartis keeps inclisiran available within the lipid management pathway.

Read more at NHS England ↗

Read the full item in the bulletin ↗

From NHS England’s Primary Care Bulletin, issue 362, 23 October 2025. Also in the bulletin on 6 Nov. Headline is NHS England’s; summary by BLMC. The full bulletin is also published on patient.info.